Modulation of the Cellular Expression of Circulating Advanced Glycation End-Product Receptors in Type 2 Diabetic Nephropathy
Open Access
- 1 January 2010
- journal article
- research article
- Published by Wiley in Experimental Diabetes Research
- Vol. 2010, 1-9
Abstract
Background. Advanced glycation end-products (AGEs) and their receptors are prominent contributors to diabetic kidney disease.Methods. Flow cytometry was used to measure the predictive capacity for kidney impairment of the AGE receptors RAGE, AGE-R1, and AGE-R3 on peripheral blood mononuclear cells (PBMCs) in experimental models of type 2 diabetes (T2DM) fed varied AGE containing diets and in obese type 2 diabetic and control human subjects.Results. Diets high in AGE content fed to diabetic mice decreased cell surface RAGE on PBMCs and in type 2 diabetic patients with renal impairment (RI). All diabetic mice had elevated Albumin excretion rates (AERs), and high AGE fed dbdb mice had declining Glomerular filtration rate (GFR). Cell surface AGE-R1 expression was also decreased by high AGE diets and with diabetes in dbdb mice and in humans with RI. PBMC expression of AGE R3 was decreased in diabetic dbdb mice or with a low AGE diet.Conclusions. The most predictive PBMC profile for renal disease associated with T2DM was an increase in the cell surface expression of AGE-R1, in the context of a decrease in membranous RAGE expression in humans, which warrants further investigation as a biomarker for progressive DN in larger patient cohorts.Keywords
Funding Information
- Juvenile Diabetes Research Foundation International
- National Institutes of Health
- National Health and Medical Research Council
This publication has 36 references indexed in Scilit:
- In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuriaKidney International, 2010
- Oral Glycotoxins Determine the Effects of Calorie Restriction on Oxidant Stress, Age-Related Diseases, and LifespanThe American Journal of Pathology, 2008
- Reduced Oxidant Stress and Extended Lifespan in Mice Exposed to a Low Glycotoxin DietThe American Journal of Pathology, 2007
- Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptorProceedings of the National Academy of Sciences, 2006
- Upregulation of RAGE and its ligands in proliferative retinal diseaseExperimental Eye Research, 2006
- Galectin‐3/AGE‐receptor 3 knockout mice show accelerated AGE‐induced glomerular injury: evidence for a protective role of galectin‐3 as an AGE receptorThe FASEB Journal, 2004
- Differential expression of renal AGE-receptor genes in NOD mice: Possible role in nonobese diabetic renal diseaseKidney International, 2000
- Differential expression of renal AGE-receptor genes in NOD mice: Possible role in nonobese diabetic renal diseaseKidney International, 2000
- Role of galectin-3 as a receptor for advanced glycosylation end productsKidney International, 2000
- The N‐oligosaccharyltransferase complex from yeastFEBS Letters, 1994